(Q34451862)

2 August 2017

1 reference

title

Papillomavirus-like particle based vaccines: cervical cancer and beyond (English)

1 reference

2 August 2017

main subject

cervix uterine cancer

1 reference

Schiller JT

1

1 reference

2 August 2017

Lowy DR

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

571-581

1 reference

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Human papillomavirus life cycle: active and latent phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Papillomavirus-like particles and HPV vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Chimeric papillomavirus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Multiple mechanisms underlie HLA dysregulation in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Neutralizing antiviral B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Early phase in the infection of cultured cells with papillomavirus virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Clinical trials of antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Receptor editing and commitment in B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Molecular mimicry and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.571

21 January 2018

Identifiers

DOI

10.1517/14712598.1.4.571

1 reference

release_5kex6yr7kfahbmvcosq7hrnxny

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5kex6yr7kfahbmvcosq7hrnxny

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference